X-COR Therapeutics
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
127 Western Ave, Allston, Massachusetts,...Website
www.xcortherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About X-COR Therapeutics
X-COR Therapeutics is a Boston-based medical device company creating the first commercially available carbon dioxide removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure. X-COR's novel technology is a patent-pending medical device and accompanying control algorithm that enables physicians to directly remove excess carbon dioxide from lung failure patients. It was founded in 2017.Explore more
X-COR Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is X-COR Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on X-COR Therapeutics recently announced quarterly report
Check out if X-COR Therapeutics is spiking on competitors!
Click to see if X-COR Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at X-COR Therapeutics
Check if X-COR Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
X-COR Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when X-COR Therapeutics launches new products
Funding: Get notified immidiatlly once X-COR Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to X-COR Therapeutics
Compare insights from companies similar to X-COR Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
X-COR Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
X-COR Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about X-COR Therapeutics.
X-COR Therapeutics financials insights
Gather financial insights about X-COR Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$2.6M
X-COR Therapeutics Tech Stack
A closer look at the technologies used by X-COR Therapeutics
See more technologies
X-COR Therapeutics News & Media
X-COR Therapeutics, an Alira Health Ventures Portfolio Company, Closes Initial $2.6M Funding Round.
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, congratulates X-COR Therapeutics for closing a $2.6M seed financing to continue developing its novel extracorporeal carbon dioxide removal device toward clinical trials. Alira Health’s investment arm, Alira Health Ventures, added X-COR Therapeutics in 2019 as a portfolio company and led the recent seed financing with syndication from Good Growth Capital, Pi
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding X-COR Therapeutics
Sign Up For FreeTo access detailed company insights
X-COR Therapeutics is a Boston-based medical device company creating the first commercially available carbon dioxide removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure. X-COR's novel technology is a patent-pending medical device and accompanying control algorithm that ena... Read More
